Specializing in healthcare solutions, the company has FDA-approved drugs for rare diseases, with active involvement in 11 conditions, including various pheochromocytoma syndromes.
3
Orphan Designations
8
FDA Approvals
11
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| adrenal gland pheochromocytoma | AdreView | Orphan Designation | - |
| hypotonia-failure to thrive-microcephaly syndrome | Adreview | Orphan Designation | - |
| insensitivity to pain with hyperplastic Myelinopathy | Adreview | Orphan Designation | - |
| malignant pancreatic neoplasm | [68Ga]FAPI-46 | Orphan Designation | - |
| pheochromocytoma | AdreView | Orphan Designation | - |
| pheochromocytoma/paraganglioma syndrome 1 | AdreView | Orphan Designation | - |
| pheochromocytoma/paraganglioma syndrome 2 | AdreView | Orphan Designation | - |
| pheochromocytoma/paraganglioma syndrome 4 | AdreView | Orphan Designation | - |
| retinal neuroblastoma | Adreview | Orphan Designation | - |
| retroperitoneal neuroblastoma | Adreview | Orphan Designation | - |
| twin to twin transfusion syndrome | AdreViewAdreview | Orphan Designation | - |